Francesca Polini

Use of varenicline in smokeless tobacco cessation influences sleep quality and dream recall frequency but not dream affect.

Sleep Medicine February 2017 Francesca Polini, Rosastella Principe, Serena Scarpelli et al.

Varenicline (VCL) treatment has become popular as a part of smoking-cessation therapies, even though its possible implications in neuropsychiatric adverse events include abnormal sleep and nightmares. Our study is the first aimed at prospectively investigating changes in sleep and dream measures across such treatment by using a one week sleep diary and collecting dream recall (DR). Thirty-eight...